how to run igf 1 lr3 IGF-1LR3 IGF-1 LR3 Peptide Dosage Guide:

Brain Res Rev 2007

Anecdotal reports from users have included: Commonly Reported: Injection site pain, redness, or swelling Mild dizziness Nausea Fatigue or drowsiness Less Commonly Reported: Anxiety or mood changes Heart palpitations Insomnia Loss of appetite Depression or anhedonia The FDA has noted that BPC-157 may pose an immunogenicity risk (triggering an immune response)

If more than 3 days have passed, skip that dose completely and resume your regular weekly schedule

Units = (dose concentration) 100

What to do: Stay consistent

The rectal administration is also beneficial for patients who may have difficulty swallowing pills or for those who have gastrointestinal issues that could interfere with the absorption of oral medications